Research and Development

Showing 15 posts of 9603 posts found.

Abbott picture

Abbott signs $400 million deal with Reata

December 13, 2011 Research and Development, Sales and Marketing Abbott

Abbott has signed a new deal with inflammatory specialist Reata for its portfolio of early-stage compounds. Abbott and Reata Pharmaceuticals …

Katherine Baicker elected to Lilly’s board of directors

December 12, 2011 Business Services, Research and Development, Sales and Marketing lilly

Lilly has elected Katherine Baicker as a new member of its board of directors, effective immediately. Baicker, 40, is Professor …
Tyverb picture

GSK’s Tyverb fails late-stage trial in breast cancer

December 12, 2011 Research and Development, Sales and Marketing GSK, Tyverb, breast cancer

GlaxoSmithKline’s Tyverb has failed to help women with HER2 positive breast cancer increase their survival.  The TEACH study’s primary objective …
Jim Easton picture

Who’s really in charge of the new NHS?

December 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS reform

Each year the health service, the Department of Health and the UK pharmaceutical industry get an opportunity to say what …

Janssen inks $150m deal for blood cancer drug

December 12, 2011 Research and Development, Sales and Marketing Janssen, Pharmacyclics

Janssen biotech has signed a licensing deal with Pharmacyclics for its investigational blood cancer drug. The firm has paid $150 …

Dechra Pharmaceuticals PLC FDA Approval for manufacturing at Dales Pharmaceuticals

December 9, 2011 Manufacturing and Production, Research and Development FDA Approval

Dechra® Pharmaceuticals PLCFDA APPROVAL FOR MANUFACTURING AT DALES® PHARMACEUTICALS  Dales Pharmaceuticals (‘Dales’ or the ‘Company’), based in Skipton, North Yorkshire, UK, …

Dr Rajeev Venkayya to head Takeda’s new vaccine business

December 9, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …
Roche picture

Roche’s new breast cancer drug succeeds in late-stage trial

December 9, 2011 Research and Development, Sales and Marketing Roche, breast cancer, pertuzumab

Roche’s next generation breast cancer drug pertuzumab has helped patients to live over six months longer. CLEOPATRA, the first randomised …
AstraZeneca's global headquarters in London

AstraZeneca to cut 1,150 staff in the US

December 8, 2011 Research and Development, Sales and Marketing AstraZeneca, cuts

AstraZeneca will cut around 1,150 positions in the US as large patent expiries loom. The cuts will come primarily from …

Deepak Khanna becomes new ABPI president-elect

December 8, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna

Deepak Khanna, senior vice president and UK managing director of Merck, Sharp and Dohme has been named as president-elect of …
Merck picture

Merck establishes new R&D centre in China

December 8, 2011 Research and Development, Sales and Marketing

Merck is moving further into China by establishing its new Asian research and development headquarters in Beijing.  The Wangjing Park …

New EU Cosmetics Regulation

December 7, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The European Cosmetics Directive has been recast and the new legislation takes the form of Regulation 1223/2009.  As a Regulation, …

Roche unveils Zurich translational partnership

December 7, 2011 Research and Development Roche, Zurich, academic alliance, translational research

Roche has unveiled a new research collaboration with academic researchers and leading clinical centres in Switzerland. The Basel-based pharma company …
lamattinalee

Big pharma: big rewards come from big risks

December 5, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, R&D productivity

John LaMattina joined Pfizer in 1977 after having completed his PhD in organic chemistry, and moved up through the ranks …

AstraZeneca to freely share drug compounds with UK groups

December 5, 2011 Research and Development, Sales and Marketing AstraZeneca, research

AstraZeneca will make 22 of its compounds available free of charge to UK academia next year as part of a …
The Gateway to Local Adoption Series

Latest content